Table 4 The difference of drug susceptibility between Beijing genotype family and non-Beijing genotype family when considered first-line drug resistance (n = 1189)
Characteristic | Category | Total | New cases | Retreated cases | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of reported cases | Beijing family (%) | Non-Beijing family (%) | OR (95% CI) | p value | Number of reported cases | Beijing family (%) | Non-Beijing family (%) | OR (95% CI) | p value | Number of reported cases | Beijing family (%) | Non-Beijing family (%) | OR (95% CI) | p value | ||
All | Â | 1189 | 990 | 199 | Â | Â | 1065 | 885 | 180 | Â | Â | 124 | 105 | 19 | Â | Â |
DST profile | Pansusceptible | 849 | 710(71.7) | 139(69.9) | 1.027(0.930–1.134) | 0.325 | 800 | 667(75.4) | 133(73.9) | 1.020(0.928–1.121) | 0.348 | 49 | 43(41) | 6(31.6) | 1.297(0.644–2.613) | 0.221 |
|  | INH | 205 | 161(16.3) | 44(22.1) | 0.736(0.547–0.989) | 0.032 | 141 | 110(12.4) | 31(17.2) | 0.722(0.501–1.040) | 0.042 | 64 | 51(48.6) | 7(36.9) | 1.318(0.709–2.453) | 0.173 |
|  | RIF | 119 | 99(10) | 20(10.1) | 0.995(0.631–1.569) | 0.534 | 64 | 53(6) | 11(6.1) | 0.980(0.522–1.839) | 0.475 | 55 | 46(43.8) | 9(47.4) | 0.925(0.549–1.557) | 0.337 |
|  | SM | 226 | 185(18.7) | 41(20.6) | 0.907(0.670–1.227) | 0.295 | 176 | 143(16.2) | 33(18.3) | 0.881(0.625–1.242) | 0.237 | 50 | 42(40) | 8(42.1) | 0.950(0.534–1.692) | 0.431 |
|  | EMB | 161 | 129(13) | 32(16.1) | 0.810(0.568–1.157) | 0.151 | 117 | 92(10.4) | 25(13.9) | 0.748(0.496–1.130) | 0.086 | 44 | 37(35.2) | 7(36.9) | 0.956(0.503–1.820) | 0.447 |
|  | MDR | 107 | 88(8.9) | 19(9.6) | 0.931(0.581–1.492) | 0.427 | 58 | 48(5.4) | 10(5.6) | 0.976(0.503–1.893) | 0.473 | 49 | 40(38.1) | 9(47.4) | 0.804(0.472–1.370) | 0.224 |